Possis takes more powerful clot-removing catheter to the US:
This article was originally published in Clinica
Possis Medical has released for sale in the US a version of its AngioJet thrombectomy catheter that can provide over twice the clot-removing power of its 4 French XMI and previous Spiroflex catheters. The device, called Spiroflex VG, is also the first AngioJet catheter of its size to be offered in a rapid exchange platform. It is available in the US for peripheral use only, though the Minneapolis, Minnesota firm plans to submit to the FDA a marketing application for coronary use in the coming weeks. Elsewhere, European CE- mark approval for the coronary and peripheral indications are pending.